AttoDx

Launched: 

2010

Sector: 

AttoDx is a biotechnology company developing applications for its proprietary Molecular Viability Testing (MVT). They partner with other companies and institutions to integrate this technology into various detection and diagnostic devices and instruments. 

Team: 

James Davie, Founder, President, CEO
Paul Harris, VP Product Development
erry Cangelosi, Consulting Scientific Director, Associate Professor in Epidemiology and in Global Heath, University of Washington
Scott Meschke, Consulting Scientist
Harvey Hoyt, Consulting Medical Director